Advancing T-cell Engagers for Solid Tumors
Time: 11:30 am
day: Day One
Details:
- T cell engager molecules have demonstrated clinical benefit in hematological malignancies and there is growing evidence of activity in solid tumors
- This presentation will highlight key findings from recent trials along with observations from nonclinical studies that inform on T cell engager molecule mechanism of action and new engineering approaches to address clinically-observed challenges